1887

oa SA Pharmaceutical Journal - Fixed-combination inhalers for asthma and chronic obstructive pulmonary disease : review

 

Abstract

Differentiating between asthma and chronic obstructive pulmonary disease (COPD) remains clinically challenging, but is essential for the appropriate management and optimisation of clinical outcomes in patients. In many countries, the majority of patients are prescribed long-acting, inhaled β-agonists and inhaled corticosteroids as maintenance treatment for asthma and COPD. Compliance with these medications is often poor, particularly in the case of inhaled corticosteroids, as these medicines do not provide immediate relief from symptoms. Various studies have concluded that patients prefer using fixed-combination inhalers and that these treatments may improve compliance and achieve better disease control.

Loading

Article metrics loading...

/content/mp_sapj/80/9/EJC144413
2013-10-01
2016-12-07
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error